Company intelligence / Profile preview

KVC Biopharma

Ownership: Private
Employees: ~1
Development stage: Other

Overview

KVC Biopharma provides consulting services for early and late phase drug development, including program leadership, CMC technical oversight for biologics manufacturing at CDMOs, non-clinical study management, bioanalytical development and clinical support. The company supports advancement of therapeutic drugs from preclinical assessment through commercial licensure

Modalities: BiologicSmall molecule
Industry: Consulting

Partnerships

Abcuro Inc. (Chief Development Officer role)Bamboo Therapeutics (COO role)

Beyond the preview

Go deeper on KVC Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KVC Biopharma.

Explore the full profile